Switch to:
Novo Nordisk A/S (NYSE:NVO)
Accounts Payable
$1,152 Mil (As of Dec. 2013)

Novo Nordisk A/S's quarterly accounts payable increased from Jun. 2013 ($1,269 Mil) to Sep. 2013 ($1,443 Mil) but then declined from Sep. 2013 ($1,443 Mil) to Dec. 2013 ($1,152 Mil).

Novo Nordisk A/S's annual accounts payable increased from Dec. 2011 ($775 Mil) to Dec. 2012 ($794 Mil) and increased from Dec. 2012 ($794 Mil) to Dec. 2013 ($1,152 Mil).


Definition

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Accts Payable 2082442984094205647467757941,152

Novo Nordisk A/S Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
Accts Payable 7827758848471,4007949041,2691,4431,152
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide